Semaglutide + pramlintide

1 paper1 finding

1 lab in 1 country

Funders: Common Fund and 3 more

Outcomes

1

Body weight

downin humans1

1 study

Semaglutide + pramlintide decreases body weight in humans.
“caloric restriction and semaglutide-pramlintide combination therapy were started at age eight and were effective in weight reduction”
Human trialin a child with Nizon-Isidor syndrome and morbid obesityfemalesn = 1
Case Series of Nizon-Isidor Syndrome by Heterozygous Variants in MED12L With Further Evidence of Mitotic Instability in One Case With Diploid-Triploid Mosaicism
American journal of medical genetics. Part A21 Aug 2025

Latest

American Journal of Medical Genetics Part A21 Aug

Case Series of Nizon-Isidor Syndrome by Heterozygous Variants in MED12L With Further Evidence of Mitotic Instability in One Case With Diploid-Triploid Mosaicism

Case seriesInterventions